Technical analysis of Lisata Therapeutics, Inc. (LSTA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues.
Price Performance
| 1 month | +33.04% |
| 3 months | -56.53% |
| Year-to-date | -17.74% |
| 1 year | -32.89% |
| 3 years | -23.50% |
| 5 years | -91.50% |
52-Week Range
| 52-week High | $5.07 |
| 52-week Low | $0.99 |
| Avg Volume (90d) | 216K |
Technical Indicators
| SMA 50 | $1.82 |
| SMA 200 | $3.11 |
| Beta | 1.11 |
| 30-day Volatility (annualised) | 132.2% |
| Price vs SMA 50 | -15.9% |
| Price vs SMA 200 | -50.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.79 | |
| 2025-11 | $2.06 | -26.2% |
| 2025-12 | $1.86 | -9.7% |
| 2026-01 | $4.63 | +148.9% |
| 2026-02 | $4.10 | -11.4% |
| 2026-03 | $5.01 | +22.2% |
| 2026-04 | $3.12 | -37.7% |
| 2026-05 | $3.25 | +4.2% |
| 2026-06 | $3.40 | +4.6% |
| 2026-07 | $0.99 | -70.9% |
| 2026-08 | $1.49 | +50.5% |
| 2026-09 | $1.53 | +2.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | $563M |
| 2026-09-14 | | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $0.20 | $23M |
| 2026-09-14 | | |
Price
| Price | $1.47 |
| Market Cap | $13M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.97 |
| EV / EBITDA | -0.01 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 5.76 |